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Introduction: Scleroderma is a chronic inﬂammatory and autoimmune disease that
leads to ﬁbrosis of the skin and visceral organs. Although interstitial pulmonary
ﬁbrosis is the most common pulmonary manifestation, pulmonary hypertension due to
pulmonary vasculopathy is also seen frequently. It is important to determine patients at
risk of developing pulmonary hypertension for prognostic reasons. In this study, risk
factors and predictors associated with the development of pulmonary hypertension in
scleroderma patients were studied.
Materials-Methods: A total of 160 patents were included in this study. A detail history
was taken, physical examination was performed, electrocardiography was obtained and
pulmonary hypertension was diagnosed ﬁrst by transthoracic echocardiography which
was then followed by right heart catheterization where the systolic, diastolic and mean
pulmonary artery pressures were obtained. High resolution computed tomography was
used to scan for interstitial pulmonary disease; besides routine biochemistry, inﬂam-
matory parameters and autoantibodies were also determined.
Results: Pulmonary hypertension was found in 15% of the patients. In univariate
analysis, the degree of tricuspid regurgitation, right ventricular diastolic diameter,
presence of pericardial effusion, pulmonary artery diameter in tomography, hemo-
globin and BNP levels were found to be associated with the development of
pulmonary hypertension. In multivariate analysis, only pulmonary artery diameter
measured in tomography and the degree of tricuspid regurgitation measured by
echocardiography were found to independent predictors of pulmonary hypertension
(p values of 0.002 and <0.001 respectively). The risk of development of pulmonary
hypertension was higher in patients with a pulmonary artery diameter >27 mm as
compared to those with a diameter 27 mm (Fig. 1 and 2). The sensitivity of
pulmonary artery diameter as a predictor was 79.1% and speciﬁcity was 92.6%,
positive predictive value was 65.5% and negative predictive value was 96.2%.
Discussion: Pulmonary hypertension accompanying scleroderma causes a signiﬁcant
decrease in survival of these patients. The determination of patients at risk of
developing pulmonary hypertension is very important for intensiﬁcation of therapy
and early intervention. In this study, pulmonary artery diameter measured in computed
tomography was found to predict scleroderma patients at risk of developing pulmo-
nary hypertension with a high accuracy and early in the course of the disease.
Table 1
Age 63 (51-75)
Female sex 14 (%42,4)
Male sex 19 (%57,6)
Diabetes mellitus 17 (%51,5)
Hypertension 23 (%69,7)
Chronic obstructive pulmonary disease 10 (%30,3)
Deep venous thrombosis 5 (%15,2)
History of malignancy 3 (%9,1)
Hemodynamic Instability 27 (%81,8)
Total hospitalization time 8,39 (6,5-10) days
Hospitalization to death time 6,5 (2-10) days
Death 7 (%21,2)
Survivors 26 (%78,8)
Smoking 16 (%48,5)
Thrombolytic therapy 5 (%15,2)
Minor bleeding 4 (%12,1)
Major bleeding 0 (%0)
Troponin I 5 (0 – 1,3) mg/dl
D-dimer 3800 (2054-5300)
Hemogram 11,58 (10,65-12,9)
QT dispersion 77 (68-94,3)
P wave dispersion 55,5 (41,8-63,5)
Longest P wave duration 104,5 (95,8-114,5)
Shortest P wave duration 45,5 (41,5-54,5)
Baseline characteristics of the study population.
Table 2
Deaths
(n¼7)
Survivors
(n¼26) p
Age 70(64-77) 62 (50-75) 0,330
Female Sex
Male sex
2 (%28,6)
5 (%71,4)
12 (%46,2)
14 (%53,8)
0,670
Deep venous
thrombosis
1 (%14,3) 4 (%15,4) 1,0
Diabetes mellitus 3 (%42,9) 14 (%53,8) 0,688
Hypertension 5 (%71,4) 18 (%69,2) 1,0
Chronic obstructive
pulmonary disease
1 (%14,3) 9 (%34,6) 0,397
Malignancy 2 (%28,6) 1 (%3,8) 0,106
Smoking 5 (%71,4) 11 (%42,3) 0,225
Hemodynamic
Instability
4 (%57,1) 23 (%88,5) 0,93
Corrected QT
interval dispersion
119 (103-120) 76 (66,5-88,5) 0,000
P wave dispersion 73 (69,5-82,5) 51 (39,6-57,6) 0,000
Hemoglobin 10,6 (9-11,3) 12 (11-13,3) 0,034
Troponin I 17 (1,4-27) 0 (0,0-0,0) 0,01
D-dimer 5200 (3200-5800) 3650 (1600-5150) 0,268
Thrombolytic
administered
not-administered
2 (%28,6)
5 (%71,4)
3 (%11,5)
23 (%88,5)
0,282
Minor bleeding 1 (%14,3) 3 (%11,5) 1,0
Comparison of baseline characteristics of the deaths and survivors in the course of acute
pulmonary embolism.
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